BernardB.GrangerBernardB., SimonaS.AlbuSimonaS., The haloperidol story, „Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists”, 17 (3), 2005, s. 137–140, DOI: 10.1080/10401230591002048, PMID: 16433054 [dostęp 2022-10-18](ang.).
P.A.P.A.JanssenP.A.P.A. i inni, Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-phenylpiperidino)butyrophenone. I. Synthesis and screening data in mice, „Journal of Medicinal and Pharmaceutical Chemistry”, 1, 1959, s. 281–297, DOI: 10.1021/jm50004a007, PMID: 14406750 [dostęp 2022-10-18](ang.).
K.K.IgarashiK.K. i inni, Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP, „Life Sciences”, 57 (26), 1995, s. 2439–2446, DOI: 10.1016/0024-3205(95)02240-5, PMID: 8847965 [dostęp 2022-10-18](ang.).
E.E.UsukiE.E. i inni, Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes, „Chemical Research in Toxicology”, 9 (4), 1996, s. 800–806, DOI: 10.1021/tx960001y, PMID: 8831826 [dostęp 2022-10-18](ang.).
D.W.D.W.EylesD.W.D.W. i inni, Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem, „Life Sciences”, 60 (8), 1997, s. 529–534, DOI: 10.1016/s0024-3205(96)00656-x, PMID: 9042387 [dostęp 2022-10-18](ang.).
Ho-JinH.J.KangHo-JinH.J. i inni, Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters, „Drug Metabolism and Disposition: The Biological Fate of Chemicals”, 34 (7), 2006, s. 1145–1151, DOI: 10.1124/dmd.105.009126, PMID: 16624869 [dostęp 2022-10-18](ang.).
Kathryn M.K.M.AventKathryn M.K.M., J.J.J.J.DeVossJ.J.J.J., Elizabeth M.J.E.M.J.GillamElizabeth M.J.E.M.J., Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites, „Chemical Research in Toxicology”, 19 (7), 2006, s. 914–920, DOI: 10.1021/tx0600090, PMID: 16841959 [dostęp 2022-10-18](ang.).
BernardB.GrangerBernardB., SimonaS.AlbuSimonaS., The haloperidol story, „Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists”, 17 (3), 2005, s. 137–140, DOI: 10.1080/10401230591002048, PMID: 16433054 [dostęp 2022-10-18](ang.).
P.A.P.A.JanssenP.A.P.A. i inni, Chemistry and pharmacology of CNS depressants related to 4-(4-hydroxy-phenylpiperidino)butyrophenone. I. Synthesis and screening data in mice, „Journal of Medicinal and Pharmaceutical Chemistry”, 1, 1959, s. 281–297, DOI: 10.1021/jm50004a007, PMID: 14406750 [dostęp 2022-10-18](ang.).
K.K.IgarashiK.K. i inni, Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP, „Life Sciences”, 57 (26), 1995, s. 2439–2446, DOI: 10.1016/0024-3205(95)02240-5, PMID: 8847965 [dostęp 2022-10-18](ang.).
E.E.UsukiE.E. i inni, Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes, „Chemical Research in Toxicology”, 9 (4), 1996, s. 800–806, DOI: 10.1021/tx960001y, PMID: 8831826 [dostęp 2022-10-18](ang.).
D.W.D.W.EylesD.W.D.W. i inni, Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem, „Life Sciences”, 60 (8), 1997, s. 529–534, DOI: 10.1016/s0024-3205(96)00656-x, PMID: 9042387 [dostęp 2022-10-18](ang.).
Ho-JinH.J.KangHo-JinH.J. i inni, Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters, „Drug Metabolism and Disposition: The Biological Fate of Chemicals”, 34 (7), 2006, s. 1145–1151, DOI: 10.1124/dmd.105.009126, PMID: 16624869 [dostęp 2022-10-18](ang.).
Kathryn M.K.M.AventKathryn M.K.M., J.J.J.J.DeVossJ.J.J.J., Elizabeth M.J.E.M.J.GillamElizabeth M.J.E.M.J., Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites, „Chemical Research in Toxicology”, 19 (7), 2006, s. 914–920, DOI: 10.1021/tx0600090, PMID: 16841959 [dostęp 2022-10-18](ang.).